217 related articles for article (PubMed ID: 23317181)
1. Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.
Yin PH; Liu X; Qiu YY; Cai JF; Qin JM; Zhu HR; Li Q
Asian Pac J Cancer Prev; 2012; 13(11):5339-43. PubMed ID: 23317181
[TBL] [Abstract][Full Text] [Related]
2. Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways.
Qi F; Inagaki Y; Gao B; Cui X; Xu H; Kokudo N; Li A; Tang W
Cancer Sci; 2011 May; 102(5):951-8. PubMed ID: 21288283
[TBL] [Abstract][Full Text] [Related]
3. [Research progress of in vitro and in vivo anti-tumor effects and formulation of bufalin].
Xu Y; Chen M; Jin XF; Qian C; Xu XM; Zhang X
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2829-33. PubMed ID: 25423817
[TBL] [Abstract][Full Text] [Related]
4. Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway.
Zhu Z; Sun H; Ma G; Wang Z; Li E; Liu Y; Liu Y
Int J Mol Sci; 2012; 13(2):2025-2035. PubMed ID: 22408435
[TBL] [Abstract][Full Text] [Related]
5. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.
Wu SH; Bau DT; Hsiao YT; Lu KW; Hsia TC; Lien JC; Ko YC; Hsu WH; Yang ST; Huang YP; Chung JG
Environ Toxicol; 2017 Apr; 32(4):1305-1317. PubMed ID: 27444971
[TBL] [Abstract][Full Text] [Related]
6. Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells.
Takai N; Kira N; Ishii T; Yoshida T; Nishida M; Nishida Y; Nasu K; Narahara H
Asian Pac J Cancer Prev; 2012; 13(1):399-402. PubMed ID: 22502710
[TBL] [Abstract][Full Text] [Related]
7. Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway.
Dong Y; Yin S; Li J; Jiang C; Ye M; Hu H
Apoptosis; 2011 Apr; 16(4):394-403. PubMed ID: 21259053
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice.
Han KQ; Huang G; Gu W; Su YH; Huang XQ; Ling CQ
World J Gastroenterol; 2007 Jun; 13(24):3374-9. PubMed ID: 17659679
[TBL] [Abstract][Full Text] [Related]
9. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
10. Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression.
Zhu Z; Li E; Liu Y; Gao Y; Sun H; Wang Y; Wang Z; Liu X; Wang Q; Liu Y
Acta Haematol; 2012; 128(3):144-50. PubMed ID: 22890165
[TBL] [Abstract][Full Text] [Related]
11. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
[TBL] [Abstract][Full Text] [Related]
12. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.
Li D; Qu X; Hou K; Zhang Y; Dong Q; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Jan; 20(1):59-64. PubMed ID: 19343001
[TBL] [Abstract][Full Text] [Related]
13. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
[TBL] [Abstract][Full Text] [Related]
14. Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress.
Zhai B; Hu F; Yan H; Zhao D; Jin X; Fang T; Pan S; Sun X; Xu L
PLoS One; 2015; 10(9):e0138485. PubMed ID: 26381511
[TBL] [Abstract][Full Text] [Related]
15. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
Hong SH; Choi YH
Oncol Rep; 2012 Jan; 27(1):114-20. PubMed ID: 21901250
[TBL] [Abstract][Full Text] [Related]
16. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.
Yeh JY; Huang WJ; Kan SF; Wang PS
Prostate; 2003 Feb; 54(2):112-24. PubMed ID: 12497584
[TBL] [Abstract][Full Text] [Related]
17. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
Liu M; Feng LX; Sun P; Liu W; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
PLoS One; 2016; 11(7):e0159789. PubMed ID: 27459387
[TBL] [Abstract][Full Text] [Related]
18. Bufalin for an innovative therapeutic approach against cancer.
Soumoy L; Ghanem GE; Saussez S; Journe F
Pharmacol Res; 2022 Oct; 184():106442. PubMed ID: 36096424
[TBL] [Abstract][Full Text] [Related]
19. Bufalin Induces Apoptotic Cell Death in Human Nasopharyngeal Carcinoma Cells through Mitochondrial ROS and TRAIL Pathways.
Su EY; Chu YL; Chueh FS; Ma YS; Peng SF; Huang WW; Liao CL; Huang AC; Chung JG
Am J Chin Med; 2019; 47(1):237-257. PubMed ID: 30612454
[TBL] [Abstract][Full Text] [Related]
20. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y
Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
